Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VIVITROL in Alcohol Dependence Post-Inpatient
NCT00501631Phase 3Completed
- Sponsor
- Alkermes
- Start
- Jul 2007
- Primary completion
- Jan 2011
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in alcohol dependence comparing VIVITROL 380 mg with Placebo (2 arms). Primary endpoint: Cumulative Percentage of Participants by Heavy Drinking Rate at 12 weeks. Started Jul 2007; status: completed.
02
Drugs
naltrexone
03
Conditions
alcohol dependence
Beyond the preview
Go deeper on NCT00501631.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00501631.